acquired
Stage
About
FORUS Therapeutics is a Canadian biopharmaceutical company developing novel medicines for hematologic malignancies and other cancers, including licensed therapies such as BESREMI® for polycythemia vera.
Explore FORUS Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.